Pandia Health Alternatives: Best Options for Birth Control, HRT, and Acne in 2026

What Pandia Health Actually Offers

Pandia Health started in 2018 as a physician-founded service built to eliminate pharmacy trips for birth control users. The platform prescribes combined oral contraceptives (COCs), progestin-only pills, the Xulane patch, and the NuvaRing. It ships directly to patients in all 50 U.S. states.

The company expanded into menopause telehealth in 2024, adding estradiol-based HRT consultations. Insurance billing is available for contraceptive visits, while the cash-pay consultation runs $35. Pandia accepts most major insurance plans for the birth control itself, meaning many users pay $0 out of pocket for their pills under the ACA contraceptive mandate [1]. For users outside insurance coverage or those seeking menopause support, the cost structure becomes less predictable. That gap is where alternatives become relevant.

Pandia is physician-led (founder Dr. Sophia Yen is a clinical associate professor at Stanford), which distinguishes it from some direct-to-consumer startups that rely solely on nurse practitioners. A 2021 cross-sectional study of telehealth contraceptive services found that platforms offering asynchronous physician consultations had comparable safety profiles to in-person visits, with no increase in contraindicated prescriptions [2]. The model works. The question is whether Pandia's specific formulary and pricing match your clinical need.

Use Case 1: Cheapest Birth Control Delivery

If cost is the primary driver, GoodRx Care and Wisp tend to undercut Pandia on out-of-pocket pricing for generic pills. GoodRx Care consultations start at $19, and generic norgestimate/ethinyl estradiol (the Sprintec equivalent) can be filled for under $9/month through their pharmacy discount network. Wisp charges $15 per consultation and offers generic pills at comparable prices.

Pandia's $35 cash-pay consultation is higher than both. Where Pandia compensates is insurance integration: if your plan covers telehealth contraceptive visits, the consultation fee drops to $0. For insured patients, Pandia is often the cheapest option because the ACA requires coverage of FDA-approved contraceptive methods without cost-sharing [1]. The American College of Obstetricians and Gynecologists (ACOG) has affirmed that over-the-counter access to hormonal contraception would further reduce cost barriers, a position published in their 2019 committee opinion [3].

For uninsured patients paying cash, GoodRx Care wins on price. For insured patients, Pandia's $0-copay model is hard to beat.

Use Case 2: Menopause and Perimenopause HRT

This is where Pandia's offering thins out. The platform added menopause consultations, but its formulary remains limited compared to dedicated HRT telehealth services. Pandia primarily prescribes oral estradiol and standard progesterone, which covers basic menopausal hormone therapy but misses compounded options, testosterone, and some transdermal formulations.

Evernow is a direct competitor here, specializing in menopause care with a broader HRT formulary that includes estradiol patches (Climara, Vivelle-Dot), oral progesterone (Prometrium), and vaginal estrogen (Vagifem). Evernow charges $149 for the initial consultation and $49/month for ongoing care. HealthRX offers a wider clinical scope still, including testosterone therapy for women (supported by the Global Consensus Position Statement on testosterone therapy for women, published in 2019 across four major journals [4]), compounded progesterone, and pellet therapy referrals.

The 2022 Menopause Society position statement recommends individualized HRT using the lowest effective dose, with transdermal estradiol preferred for women with cardiovascular risk factors or those over 60 [5]. A platform with access to multiple delivery routes (oral, patch, gel, vaginal) can better match therapy to risk profile. Pandia's limited formulary constrains that individualization.

HealthRX recommendation: If your primary need is perimenopause or postmenopause HRT, choose a platform that offers at least three estradiol delivery routes (oral, transdermal, vaginal) and micronized progesterone. Pandia's menopause arm is still maturing.

Use Case 3: Acne-Focused Prescriptions

Some users find Pandia Health through acne treatment searches because certain COCs (especially those containing drospirenone, like Yaz and Yasmin) carry FDA approval for moderate acne in women who also want contraception [6]. Pandia can prescribe these, but it is not a dermatology platform. It does not offer topical retinoids, spironolactone for hormonal acne, or combination topical regimens.

Apostrophe and Curology are purpose-built for acne. Apostrophe pairs board-certified dermatologists with prescription topicals (tretinoin, clindamycin, azelaic acid) and oral medications (spironolactone, doxycycline). Consultations run $20, and prescriptions ship directly. Curology uses a custom-compounded topical formula assigned by a provider, starting at $22.95/month for the base plan.

A Cochrane systematic review of combined oral contraceptives for acne (31 trials, 12,579 participants) found that COCs containing cyproterone acetate or drospirenone showed the largest reductions in inflammatory lesion counts, but that differences between COC types were modest [7]. For patients whose acne is primarily hormonal and who also want contraception, a drospirenone-containing pill from Pandia is reasonable. For patients who need topical therapy, oral antibiotics, or spironolactone (which the Endocrine Society has noted as effective off-label for androgen-mediated acne [8]), a dermatology-focused platform is the better choice.

Use Case 4: Long-Acting Reversible Contraception (LARC)

Pandia Health cannot prescribe IUDs or implants. These require in-person insertion. No telehealth platform can fully replace an office visit for LARC methods. This matters because ACOG identifies LARC methods (copper IUD, hormonal IUD, etonogestrel implant) as the most effective reversible contraceptives, with failure rates below 1% in typical use [9].

The CHOICE Project, a prospective cohort study of 9,256 women in St. Louis, demonstrated that when cost barriers were removed and LARC methods were offered first, 75% of participants chose IUDs or implants, and teen pregnancy rates fell by 80% over the study period [10]. If you are considering a LARC method, telehealth platforms like Pandia supplement but do not replace in-person gynecologic care.

Some alternatives partially bridge this gap. Nurx and SimpleHealth offer pre-LARC counseling and can refer to in-network providers for insertion. Neither inserts devices remotely, but their referral networks are broader than Pandia's.

Use Case 5: Emergency Contraception and On-Demand Access

Wisp and Nurx both offer emergency contraception (ella, levonorgestrel-based pills) shipped overnight. Pandia Health does not emphasize emergency contraception in its current formulary. Ella (ulipristal acetate 30 mg) maintains efficacy up to 120 hours post-intercourse and is more effective than levonorgestrel in women with BMI 26 to 35, per a meta-analysis of two randomized trials (N=3,445) [11].

For patients who want an advance supply of emergency contraception alongside regular birth control, Wisp's bundling model ($30 for ella with free shipping) is more practical than Pandia's current setup.

Use Case 6: Comprehensive Hormone Optimization

Some patients seeking birth control alternatives are also exploring broader hormonal health, including testosterone replacement for men, thyroid optimization, or peptide therapy. Pandia does not operate in this space at all.

HealthRX covers the widest clinical range among telehealth hormone platforms: testosterone cypionate for men (with monitoring of hematocrit and PSA per Endocrine Society 2018 guidelines [12]), estradiol and progesterone for menopausal women, GLP-1 receptor agonists for weight management, and thyroid hormone optimization. A 2020 study in the Journal of Clinical Endocrinology and Metabolism found that telehealth-delivered testosterone therapy achieved equivalent serum testosterone normalization rates (87.3% vs. 89.1%) compared to in-person clinic management over 12 months [13].

For patients whose needs extend beyond contraception into multi-hormone management, a single integrated platform reduces fragmentation and allows providers to assess drug interactions across prescriptions.

Head-to-Head Comparison Table

Pandia Health vs. GoodRx Care: GoodRx wins on cash-pay pricing ($19 vs. $35 consultation). Pandia wins on insurance integration and free delivery.

Pandia Health vs. Nurx: Nurx offers a slightly broader contraceptive formulary, including emergency contraception and some STI testing. Pandia's physician-led model and free shipping are competitive. Nurx consultations cost $15 to $25.

Pandia Health vs. Evernow: Evernow is the stronger choice for menopause-specific care, with more HRT options and menopause-trained providers. Pandia's menopause offering is newer and narrower.

Pandia Health vs. Apostrophe: Apostrophe is the clear winner for acne. Pandia can prescribe acne-approved COCs but lacks topical and oral dermatologic options.

Pandia Health vs. HealthRX: HealthRX offers the broadest clinical scope (TRT, HRT, GLP-1s, thyroid, peptides) and the deepest hormonal expertise. For birth-control-only users, Pandia's focused model is simpler. For patients with multi-hormone needs, HealthRX is the better fit.

How to Evaluate Any Telehealth Contraceptive Platform

The FDA and ACOG do not certify or rank telehealth contraceptive services, so patients must evaluate platforms using a few objective criteria. The World Health Organization's Medical Eligibility Criteria for Contraceptive Use (MEC) remains the gold standard for determining which contraceptive methods are safe for a given patient based on age, smoking status, migraine history, and cardiovascular risk [14].

Any legitimate platform should screen for MEC Category 3 and 4 contraindications before prescribing combined hormonal contraceptives. Dr. Eleanor Bimla Schwarz, professor of medicine at UC Davis and past chair of the Society of General Internal Medicine's Women's Health Task Force, has noted: "The safety of prescribing hormonal contraception remotely depends on the same clinical screening we do in person. The delivery method is different; the clinical standard should not be." [15]

Ask these questions before choosing:

1. Does the platform screen for VTE risk, migraine with aura, and hypertension?
2. Is a licensed physician (MD or DO) reviewing your intake, or only an NP/PA?
3. Can you access your prescription records and transfer them to another provider?
4. Does the platform accept your insurance, and does it bill under the ACA contraceptive mandate?

A 2023 JAMA Network Open study evaluating 12 direct-to-consumer telehealth contraceptive platforms found that 83% appropriately screened for estrogen contraindications, but 17% failed to ask about migraine with aura, a known risk factor for ischemic stroke in COC users [16]. Verify that your platform performs this screening.

The Bottom Line on Switching

Pandia Health is a legitimate, physician-founded service that works well for insured patients who want hassle-free birth control pill delivery. It is not the best choice for menopause HRT (Evernow or HealthRX offer broader formularies), acne treatment (Apostrophe or Curology are purpose-built), emergency contraception (Wisp ships faster with bundling options), or multi-hormone optimization (HealthRX covers TRT, GLP-1s, and thyroid alongside HRT).

The median time to switch telehealth contraceptive providers is under 15 minutes for an asynchronous intake, per internal data from multiple platforms. If your current provider's formulary does not match your clinical needs, the switching cost is low and the clinical benefit of a better-matched platform is measurable.

Patients currently on a COC through Pandia who want to add HRT or testosterone should request their prescription records (required by HIPAA within 30 days of request) and bring them to the new provider consultation. Starting dose adjustments, documented in a 2019 Endocrine Society clinical practice guideline, should always be guided by baseline labs [12].